Public Health Situation Analysis and Interventions 10 October 2017
Moving from accelerated burden reduction to malaria elimination in Zambia
TB policies in 29 Countries
A survey of prevention, testing and treatment policies and practices
Trials (2017) 18:152, DOI 10.1186/s13063-017-1881-z
Tuberculosis (TB) control in the African Region has evolved since the disease was declared a global emergency by the World Health Organization (WHO) in 1993. Member States have adopted and implemented successive global and regional strategies and resolutions, with demonstrable positive impacts on in...cidence, prevalence and mortality, albeit with variations across countries. By the end of 2015, the Region as a whole met the key Millennium Development Goal (MDG) target of halting and beginning to reverse TB incidence. However only 35 of the 47 Member States met the MDG target.
more
2nd edition.
The practical aspects of TB patient care from the onset of symptoms to the completion of treatment are covered in this guide
Blueprint for EECA countries, first edition
Scientific advice
Prevention and control of communicable diseases in prison settings.
Technical Update
HIV Treatment
July 2017
World's largest Science, Technology & Medicine Open Access book publisher
Chapter 7 from the book People's Movements in the 21st Century - Risks, Challenges and Benefits
Recommendations, resources and references
A publication of the Southern African HIV Clinicians Society
Suggested language and usage for tuberculosis communications
First edition
Accessed November 2017
HIV treatment
Policy brief
July 2017
WHO/HIV/2017.18
PQDx 0181-031-00
WHO PQ Public Report
March/2017, version 3.0
PQDx 0159-055-00
WHO PQ Public Report
February/2017, version 5.0
Guidelines
June 2017
HIV strategic information for impact
Lymphatic filariasis is a vector-borne neglected tropical disease that causes damage of the lymphatic system and can lead to lymphoedema (elephantiasis) and hydrocele in infected individuals. The global baseline estimate of persons affected by lymphatic filariasis is 25 million men with hydrocele an...d over 15 million people with lymphoedema. At least 36 million persons remain with these chronic disease manifestations. The disease is endemic in 72 countries. In 2016, an estimated total population of 856 million were living in areas with ongoing transmission of the causative filarial parasites and requiring mass drug administration (MDA). Lymphatic filariasis disfigures and disables, and often leads to stigmatization and poverty. Hundreds of millions of dollars are lost annually due to reduced productivity of affected patients. WHO has ranked the disease as one of the world’s leading causes of permanent and long-term disability.
more